Sparrow BioAcoustics Raises $13M in Seed Financing Round
Sparrow BioAcoustics, a Canadian startup specializing in bioacoustic AI technology, has secured $13 million in seed financing.
The seed financing round for Sparrow BioAcoustics was led by Killick Capital, Klister Credit, and Pelorus Ventures. This significant investment represents a major milestone for Sparrow as it continues to advance in the medical AI sector.
The company’s core innovation is a smartphone-based tool that enables users to capture and analyze heart sounds for early detection of cardiac issues.
Dr. Yaroslav Shpak, Chief Medical Officer of Sparrow BioAcoustics said:
"There is a future where people can screen for cardiac and pulmonary problems anywhere any time, and that future is really close now."
With a 96% success rate on first-time use, Sparrow’s technology has already facilitated 30,000 medical-grade heart recordings over the past few months.
Their product, categorized as Software as a Medical Device (SaMD), is also FDA-approved, boosting its credibility in the health-tech field.
Sparrow's next steps include further product developments aimed at making heart and lung condition screening more accessible, anytime and anywhere.
With this recent funding of a whopping $13 million, the Sparrow BioAcoustics team is set to accelerate their plans, anticipating more breakthroughs in the coming weeks.
The company’s rapid growth and innovative solutions reflect growing confidence in its potential to transform how cardiac health is monitored and managed, directly from a smartphone.
